Your browser doesn't support javascript.
loading
Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.
Eberlein, Michael; Reed, Robert M; Bolukbas, Servet; Diamond, Joshua M; Wille, Keith M; Orens, Jonathan B; Brower, Roy G; Christie, Jason D.
Afiliação
  • Eberlein M; Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa. Electronic address: michael-eberlein@uiowa.edu.
  • Reed RM; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Bolukbas S; Department of Thoracic Surgery, Dr. Horst Schmidt Klinik, Wiesbaden, Germany.
  • Diamond JM; Division of Pulmonary and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wille KM; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Orens JB; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Brower RG; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Christie JD; Division of Pulmonary and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
J Heart Lung Transplant ; 34(2): 233-40, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25447586
BACKGROUND: Donor-to-recipient lung size matching at lung transplantation (LTx) can be estimated by the predicted total lung capacity (pTLC) ratio (donor pTLC/recipient pTLC). We aimed to determine whether the pTLC ratio is associated with the risk of primary graft dysfunction (PGD) after bilateral LTx (BLT). METHODS: We calculated the pTLC ratio for 812 adult BLTs from the Lung Transplant Outcomes Group between March 2002 to December 2010. Patients were stratified by pTLC ratio >1.0 ("oversized") and pTLC ratio ≤1.0 ("undersized"). PGD was defined as any ISHLT Grade 3 PGD (PGD3) within 72 hours of reperfusion. We analyzed the association between risk factors and PGD using multivariable conditional logistic regression. As transplant diagnoses can influence the size-matching decisions and also modulate the risk for PGD, we performed pre-specified analyses by assessing the impact of lung size mismatch within diagnostic categories. RESULTS: In univariate analyses oversizing was associated with a 39% lower odds of PGD3 (OR 0.61, 95% CI, 0.45-0.85, p = 0.003). In a multivariate model accounting for center-effects and known PGD risks, oversizing remained independently associated with a decreased odds of PGD3 (OR 0.58, 95% CI 0.38 to 0.88, p = 0.01). The risk-adjusted point estimate was similar for the non-COPD diagnosis groups (OR 0.52, 95% CI 0.32 to 0.86, p = 0.01); however, there was no detected association within the COPD group (OR 0.72, 95% CI 0.29 to 1.78, p = 0.5). CONCLUSION: Oversized allografts are associated with a decreased risk of PGD3 after BLT; this effect appears most apparent in non-COPD patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Pulmão / Disfunção Primária do Enxerto / Pulmão Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Pulmão / Disfunção Primária do Enxerto / Pulmão Idioma: En Ano de publicação: 2015 Tipo de documento: Article